Implementation of the Australian Computer‐Assisted Theragnostics (AusCAT) network for radiation oncology data extraction, reporting and distributed learning

There is significant potential to analyse and model routinely collected data for radiotherapy patients to provide evidence to support clinical decisions, particularly where clinical trials evidence is limited or non‐existent. However, in practice there are administrative, ethical, technical, logistical and legislative barriers to having coordinated data analysis platforms across radiation oncology centres.

[1]  A. Dekker,et al.  Making radiotherapy more efficient with FAIR data. , 2021, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[2]  Jiazhou Wang,et al.  Distributed learning on 20 000+ lung cancer patients - The Personal Health Train. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  H. Aerts,et al.  Distributed radiomics as a signature validation study using the Personal Health Train infrastructure , 2019, Scientific Data.

[4]  P. Youl,et al.  Development and Implementation of a Cancer Quality Index in Queensland, Australia: A Tool for Monitoring Cancer Care. , 2019, Journal of oncology practice.

[5]  Jenna Wong,et al.  Using Machine Learning to Identify Health Outcomes from Electronic Health Record Data , 2018, Current Epidemiology Reports.

[6]  Alberto Traverso,et al.  The radiation oncology ontology (ROO): Publishing linked data in radiation oncology using semantic web and ontology techniques , 2018, Medical physics.

[7]  Aditya Ghose,et al.  The effect of imputing missing clinical attribute values on training lung cancer survival prediction model performance , 2017, Health Inf. Sci. Syst..

[8]  M. V. van Herk,et al.  Data Mining in Oncology: The ukCAT Project and the Practicalities of Working with Routine Patient Data. , 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

[9]  Issam El-Naqa,et al.  A prediction model for early death in non-small cell lung cancer patients following curative-intent chemoradiotherapy , 2017, Acta oncologica.

[10]  B. Solomon,et al.  Lung cancer prognostic index: a risk score to predict overall survival after the diagnosis of non-small-cell lung cancer , 2017, British Journal of Cancer.

[11]  P. Lambin,et al.  Distributed learning: Developing a predictive model based on data from multiple hospitals without data leaving the hospital - A real life proof of concept. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  M. Carolan,et al.  Development and Feasibility Testing of PROMPT-Care, an eHealth System for Collection and Use of Patient-Reported Outcome Measures for Personalized Treatment and Care: A Study Protocol , 2016, JMIR research protocols.

[13]  S. Vinod,et al.  Application of Guideline Recommended Treatment in Routine Clinical Practice: A Population-based Study of Stage I-IIIB Non-small Cell Lung Cancer. , 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

[14]  Martin Carolan,et al.  Implementation of a rapid learning platform: Predicting 2-year survival in laryngeal carcinoma patients in a clinical setting , 2016, Oncotarget.

[15]  Erik Schultes,et al.  The FAIR Guiding Principles for scientific data management and stewardship , 2016, Scientific Data.

[16]  Xiaoqian Jiang,et al.  WebDISCO: a web service for distributed cox model learning without patient-level data sharing , 2015, J. Am. Medical Informatics Assoc..

[17]  Frank Verhaegen,et al.  Modern clinical research: How rapid learning health care and cohort multiple randomised clinical trials complement traditional evidence based medicine , 2015, Acta oncologica.

[18]  W. Curran,et al.  Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. , 2015, The Lancet. Oncology.

[19]  Oliver Butters,et al.  DataSHIELD: taking the analysis to the data, not the data to the analysis , 2014, International journal of epidemiology.

[20]  Armia George,et al.  PROFFERED PAPERS: CLINICAL 2: LUNG CANCEROC-0063: Rapid learning in practice: A lung cancer survival decision support system in routine patient care data , 2014 .

[21]  P. O'Brien,et al.  Obstacles to participation in randomised cancer clinical trials: A systematic review of the literature , 2012, Journal of medical imaging and radiation oncology.

[22]  Benjamin Movsas,et al.  Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. , 2011, Journal of the National Cancer Institute.

[23]  D De Ruysscher,et al.  Comparison of Bayesian network and support vector machine models for two-year survival prediction in lung cancer patients treated with radiotherapy. , 2010, Medical physics.

[24]  Shipeng Yu,et al.  Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy. , 2009, International journal of radiation oncology, biology, physics.

[25]  Sherri de Coronado,et al.  NCI Thesaurus: A semantic model integrating cancer-related clinical and molecular information , 2007, J. Biomed. Informatics.

[26]  Jennifer P. Stevens,et al.  Using EHR to Conduct Outcome and Health Services Research , 2016 .